1 RX: 64800903TPN (1 of 4) specialty medication tolvaptan 15MG X7/ 45MG X7 dose PAK
Ended Awarded
- Contract number
- 36C24921N0203
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,035
Award facts
- Contract value 100% obligated
- $10,034.63 Current and potential, with all options
- Completion date
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. was awarded a $10,034.63 firm-fixed-price delivery order by Veterans Integrated Service Network 9 (VISN 9) on November 13, 2020, for specialty medication tolvaptan in 15mg and 45mg dose packs. This delivery order, which serves as the first of four related awards, was issued under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize any set-aside designation. The award was funded by the Department of Veterans Affairs' civilian healthcare operations and was designated for performance in Potomac, Maryland, with an ultimate completion date of November 13, 2020.
This delivery order supports the VA's mission to provide specialized pharmaceutical treatments to veterans by supplying tolvaptan, a medication used to treat complex conditions including autosomal dominant polycystic kidney disease and hyponatremia. Otsuka America Pharmaceutical Inc. maintains a substantial Blanket Purchase Agreement valued at $83.3 million with the VA's National Acquisition Center and holds a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology products, positioning the company as a significant supplier of specialty medications across multiple VA Integrated Service Networks nationwide.
Quick answers
Who was awarded contract 36C24921N0203?
36C24921N0203 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 9 (Veterans Health Administration) on November 13, 2020.
How much is contract 36C24921N0203 worth?
The government has obligated $10,035 on 36C24921N0203.
Is contract 36C24921N0203 an order under another contract?
Yes. 36C24921N0203 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24921N0203 competed?
The extent of competition for 36C24921N0203 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award